Queen’s University Belfast has a proud tradition in Cancer Research and its translation into improving the lives of our citizens, locally, nationally and internationally.

Congratulations to Dr Karl Butterworth from The Patrick G Johnston Centre for Cancer Research has won a highly prestigious international award from the Radiation Research Society in the United States.

Researchers at Queen’s University Belfast have discovered a ground-breaking therapeutic process that can target and kill bowel cancer cells, which may improve survival rates for bowel cancer patients globally.

Queen's has announced they are part of a consortium that will receive a multi-million-pound investment of government/industry funding to advance the use of artificial intelligence (AI) in cancer diagnosis and precision medicine.

In an article published this month in The Lancet Oncology, a collaborative team of international researchers led by Queen’s University Belfast, outlines the imperative for maintaining public trust in the use of health data for research.

Queen’s University Belfast will hosting AIMday Big Data, AI and the One Health Agenda on Friday 19th October 2018 at Riddel Hall, Queen’s University Belfast.

Early results from an innovative new clinical trial led by researchers from Queen’s University Belfast have shown that men with prostate cancer could benefit from radical radiotherapy that delivers treatment in just five visits.

Queen’s researchers have secured a prestigious award to develop a new antibody drug for the treatment of pancreatic cancer.

QUEEN'S UNIVERSITY SCIENTISTS INVITE CITY TO UNITE FOR WORLD CANCER DAY

A groundbreaking report, led by Professor Mark Lawler, Chair in Translational Cancer Genomics at Queen’s highlights a plan to end bowel cancer, the second most common cause of cancer death in Europe.

A £10million Centre of Excellence in Precision Medicine was launched today by Invest Northern Ireland and Queen’s University Belfast.